Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

Stomach Neoplasms

Biliary Tract Neoplasms

Gynecological Malignancy

Lymphoma, Large B-Cell, Diffuse

Solid Tumors

Advanced Malignant Tumor

Differentiated Thyroid Cancer

Recurrence, Lymphoma, Large B-Cell, Diffuse

Leukemia, Myeloid, Acute

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Advanced Solid Tumor

Advanced Solid Tumor

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Breast Neoplasms

Breast Neoplasms

Locally Advanced or Metastatic Solid Tumors

Advanced Malignant Neoplasm

Prostatic Neoplasms

Esophageal Squamous Cell Carcinoma

Pancreatic Neoplasms

Breast Neoplasms

Advanced Breast Cancer

Gastric Adenocarcinoma

Advanced Solid Tumors

Perivascular Epithelioid Cell Neoplasms

Locally Advanced/Metastatic Solid Tumours

Platinum-resistant Recurrent Ovarian Cancer

Malignant Solid Tumors

Nasopharyngeal Carcinoma

Advanced Malignant Tumors

Advanced Solid Tumor

Advanced Solid Tumors

Multiple Myeloma, Recurrence

Advanced Solid Tumors

Advanced Solid Tumors

Nasopharyngeal Carcinoma

Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Leukemia, Myeloid, Acute

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

PD-L1 Positive Non-small Cell Lung Cancer

Solid Tumor, Adult

HER2-Positive Solid Tumors

HER2-positive Advanced Breast Cancer

Carcinoma, Hepatocellular

Clinical Trials

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

DTC

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection

Pediatric_PK

A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

A Study of 7MW3711 in Subjects With Advanced Solid Tumors

Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

BC3195

Clinical Trial Evaluating the Safety of the TQB2103 for Injection

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer

A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer

A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients

A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)

Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer

A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients

A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor

A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors

Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM

The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere

A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor

Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status

A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients

The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Expanding Phase III Study of Tyroserleutide for Injection